AKT-I-1

Cat. No.: OB0225WX-1659

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: AKT-I-1 is defined as a selective and reversible chemical inhibitor specifically targeting the Akt1 isoform.

Synonym: 473382-39-7; Akt-l-1; N1-(7-cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-N3,N3,2,2-tetramethylpropane-1,3-diamine; N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine; Akt1-IN-2; N-(7-Cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-N',N',2,2-tetramethylpropane-1,3-diamine; Akt-I-1 compound; AktI 1; N'-(7-Cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-2,2,N,N-tetramethyl-propane-1,3-diamine; N'-(7-Cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-2,2,N,N-tetramethyl-propane-1.3-diamine

CAS No.: 473382-39-7

Compound CID: 10271028

Formula: C₂₂H₃₀N₆

Formula Weight: 378.51

Specification

Relative Density: 1.20 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: AKT-I-1 is applied in molecular research as a selective allosteric inhibitor of Akt1 to study the isoform-specific contributions of Akt1 to cell growth and survival.